Skip to content
OpenCapital
Get started

Twist Bioscience Corporation TWST Gain (loss) on disposal of assets

Discontinued — last reported Q3 '25

Gain (loss) on disposal of assets at other companies

Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$30M—
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
-$7M—
Revvity logo
RevvityRVTY
——

Segments

By segment

See full
Reportable Segment$48.85M—

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: Twist Bioscience Corporation’s 10-Q, filed August 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's gain (loss) on disposal of assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's gain (loss) on disposal of assets?
Twist Bioscience Corporation (TWST) reported gain (loss) on disposal of assets of $48.85M in Q2 2025.
What does gain (loss) on disposal of assets mean?
Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.